Tuesday 13 October 2026
Export NUS’s income statement to Excel — free account
Nu Skin Enterprises, Inc.
NUS Consumer Defensive Household & Personal Products
Nu Skin Enterprises, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 14.3% from fiscal 2024. In the quarter to June 2026, revenue fell 17.1%, EPS fell 1,295.4%, free cash flow fell 86.1% and total debt fell 14.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
4.87
0.13
+2.74%
Follow NUS
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
2.97 | 0.00 | 112.89 | 20.12 | 17.38 | 14.73 | 13.13 | 27.63 | 27.98 | 18.83 |
Piotroski F-Score |
7 | 4 | 5 | 5 | 6 | 6 | 6 | 5 | 7 | 7 |
Altman Z-Score |
3.78 | 2.92 | 3.46 | 4.55 | 4.98 | 4.90 | 5.02 | 5.88 | 6.11 | 5.71 |
P/S ratio |
0.32 | 0.20 | 0.51 | 0.95 | 0.95 | 1.11 | 0.94 | 1.26 | 1.59 | 1.22 |
Altman Z″-Score (non-manufacturers) |
7.36 | 5.02 | 5.78 | 6.34 | 6.24 | 6.04 | 6.65 | 6.39 | 6.66 | 6.76 |
P/FCF ratio |
10.31 | 4.88 | 16.79 | 43.11 | 34.91 | 9.06 | 20.34 | 25.56 | 14.94 | 12.01 |
Beneish M-Score |
(2.35) | (3.43) | (2.47) | (2.20) | (2.76) | (2.75) | (2.36) | (2.14) | (2.91) | (3.12) |
P/Operating CF |
28.53 | 13.27 | 18.65 | 82.77 | 23.26 | 30.17 | 45.59 | 38.07 | 24.67 | 30.08 |
Dividend Safety Score |
70 | — | — | — | — | — | — | — | — | — |
P/B ratio |
0.59 | 0.53 | 1.23 | 2.35 | 2.79 | 3.19 | 2.60 | 4.33 | 5.14 | 4.07 |
Price to Tangible BV |
0.70 | 0.69 | 1.99 | 3.38 | 4.05 | 4.75 | 3.80 | 6.83 | 6.94 | 5.57 |
EV/Sales |
0.31 | 0.31 | 0.63 | 1.00 | 0.95 | 1.07 | 0.95 | 1.28 | 1.57 | 1.25 |
EV/EBITDA |
3.89 | 0.00 | 10.45 | 12.20 | 8.28 | 8.35 | 6.66 | 10.55 | 10.32 | 9.06 |
EV/Operating CF |
5.71 | 4.81 | 10.50 | 20.70 | 18.14 | 7.30 | 12.89 | 16.85 | 11.80 | 9.99 |
EV/FCF |
9.97 | 7.67 | 20.70 | 45.64 | 35.20 | 8.78 | 20.50 | 25.81 | 14.73 | 12.23 |
Quick Ratio |
1.06 | 0.84 | 0.99 | 0.91 | 0.75 | 0.90 | 1.11 | 1.03 | 1.05 | 1.00 |
Current Ratio |
2.08 | 1.82 | 2.13 | 2.12 | 1.65 | 1.66 | 2.07 | 1.82 | 1.74 | 1.79 |
Net Debt/EBITDA |
(0.13) | (2.39) | 1.97 | 0.68 | 0.07 | (0.27) | 0.05 | 0.10 | (0.14) | 0.16 |
Debt/Assets |
15.95% | 26.80% | 27.81% | 22.10% | 19.74% | 17.14% | 20.46% | 25.40% | 24.44% | 28.28% |
Debt/Equity |
0.28 | 0.60 | 0.61 | 0.45 | 0.41 | 0.38 | 0.41 | 0.55 | 0.55 | 0.63 |
Asset Turnover |
1.03 | 1.06 | 1.09 | 1.19 | 1.40 | 1.39 | 1.40 | 1.63 | 1.49 | 1.48 |
Operating CF/Net income |
0.50 | (0.76) | 13.80 | 1.03 | 0.96 | 1.98 | 1.03 | 1.66 | 2.34 | 1.92 |
Capex/Depreciation |
(0.66) | (0.60) | (0.82) | (0.81) | (0.90) | (0.86) | (0.86) | (0.85) | (0.84) | (0.69) |
Interest Coverage |
4.71 | (5.74) | 1.89 | 8.22 | — | — | — | — | — | — |
| 22.00% | (19.90%) | 1.00% | 11.58% | 16.30% | 21.63% | 20.95% | 16.40% | 18.91% | 19.21% | |
| 11.15% | (8.95%) | 0.47% | 5.62% | 7.62% | 10.27% | 10.02% | 7.42% | 8.45% | 9.60% | |
ROIC |
5.21% | (11.18%) | 2.85% | 6.78% | 15.65% | 19.98% | 18.71% | 18.49% | 26.19% | 20.26% |
Return on Tangible Assets |
24.23% | (23.58%) | 1.07% | 12.39% | 18.48% | 23.10% | 20.73% | 14.79% | 16.28% | 18.83% |
Average Days of Receivables |
9.72 | 10.70 | 10.88 | 7.77 | 5.59 | 8.96 | 7.60 | 7.26 | 5.32 | 5.16 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
63.33% | 65.30% | 65.47% | 64.49% | 64.35% | 64.54% | 64.93% | 64.70% | 65.93% | 66.86% |
Intangible Assets out of Total Assets |
0.09 | 0.11 | 0.17 | 0.15 | 0.15 | 0.15 | 0.16 | 0.17 | 0.11 | 0.12 |
Share Based Compensation of Revenue |
1.62% | 0.86% | 0.79% | 0.56% | 0.86% | 0.93% | 0.41% | 0.99% | 0.85% | 0.40% |
Graham Net Nets |
(0.11) | (0.81) | (0.28) | (0.08) | (0.05) | (0.06) | (0.07) | (0.03) | (0.03) | (0.04) |
Graham Number |
34.51 | 0.00 | 8.18 | 29.12 | 34.57 | 37.78 | 33.27 | 26.61 | 27.12 | 26.43 |
Earnings Yield |
33.68% | (42.82%) | 0.89% | 4.97% | 5.75% | 6.79% | 7.61% | 3.62% | 3.57% | 5.31% |
Free Cash Flow Yield |
9.70% | 20.50% | 5.95% | 2.32% | 2.86% | 11.04% | 4.92% | 3.91% | 6.70% | 8.33% |
Revenue per Share |
30.13 | 34.88 | 39.61 | 44.51 | 53.71 | 49.37 | 43.60 | 48.56 | 43.16 | 39.84 |
Operating CF per Share |
1.63 | 2.25 | 2.39 | 2.16 | 2.82 | 7.25 | 3.20 | 3.67 | 5.73 | 4.97 |
Capex per Share |
(0.70) | (0.84) | (1.18) | (1.18) | (1.37) | (1.22) | (1.19) | (1.28) | (1.14) | (0.91) |
Free Cash Flow per Share |
0.93 | 1.41 | 1.21 | 0.98 | 1.45 | 6.03 | 2.01 | 2.40 | 4.59 | 4.06 |
Cash per Share |
4.87 | 3.99 | 5.39 | 5.57 | 7.07 | 8.11 | 6.20 | 7.22 | 8.30 | 6.64 |
Shareholders Equity per Share |
16.34 | 13.12 | 16.53 | 17.95 | 18.19 | 17.10 | 15.77 | 14.17 | 13.34 | 11.98 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
16.34 | 13.12 | 16.53 | 17.95 | 18.19 | 17.10 | 15.77 | 14.17 | 13.34 | 11.98 |
Free Cash Flow |
46.01 | 70.16 | 60.15 | 49.01 | 72.97 | 315.32 | 111.86 | 132.37 | 242.40 | 225.04 |
Working Capital |
283.96 | 241.99 | 373.00 | 400.63 | 343.26 | 360.34 | 383.41 | 359.58 | 330.42 | 315.33 |
Capital Expenditures |
(34.28) | (41.58) | (58.49) | (59.06) | (68.61) | (63.82) | (66.07) | (70.37) | (60.16) | (50.22) |
Net Current Asset Value |
(52.37) | (278.86) | (284.79) | (163.81) | (120.76) | (159.61) | (153.55) | (113.34) | (107.49) | (95.64) |
EV/EBIT |
6.97 | 0.00 | 25.80 | 20.18 | 10.98 | 10.75 | 8.57 | 14.18 | 13.01 | 11.90 |
Capex to Sales |
0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 |
Price to Operating Income |
7.21 | 0.00 | 20.93 | 19.06 | 10.89 | 11.09 | 8.51 | 14.05 | 13.19 | 11.69 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.14 | 0.18 | 0.16 | 0.16 | 0.17 | 0.16 | 0.17 | 0.18 | 0.15 | 0.16 |
Cash ROIC |
3.62% | 5.64% | 3.78% | 3.11% | 4.44% | 19.07% | 7.07% | 8.22% | 15.83% | 15.53% |
Accounts Receivable Turnover |
32.88 | 31.64 | 37.13 | 50.21 | 51.51 | 45.40 | 46.70 | 61.96 | 70.79 | 66.24 |
Accounts Payable Turnover |
14.86 | 14.11 | 12.61 | 12.14 | 11.63 | 12.52 | 13.43 | 12.95 | 10.96 | 14.28 |
Inventory Turnover |
2.46 | 2.34 | 1.95 | 1.69 | 1.89 | 2.23 | 2.03 | 2.31 | 1.99 | 1.94 |
Average Days of Payables |
21.06 | 23.14 | 25.72 | 31.22 | 27.02 | 36.71 | 24.47 | 27.41 | 36.60 | 30.09 |
Days of Inventory on Hand |
143.70 | 126.20 | 167.02 | 200.28 | 216.19 | 174.37 | 173.20 | 170.27 | 184.26 | 182.29 |
Average Receivables |
45.16 | 54.74 | 53.03 | 44.33 | 52.33 | 56.87 | 51.83 | 43.24 | 32.20 | 33.33 |
Average Payables |
30.53 | 39.00 | 48.54 | 51.98 | 58.08 | 52.58 | 43.30 | 48.98 | 45.80 | 35.05 |
Average Inventory |
184.44 | 235.11 | 313.08 | 373.06 | 357.15 | 295.13 | 285.86 | 274.64 | 251.70 | 257.60 |
Average Assets |
1,437.11 | 1,638.77 | 1,814.80 | 1,863.73 | 1,931.78 | 1,863.04 | 1,731.73 | 1,642.16 | 1,531.96 | 1,489.94 |
Average Common Equity |
728.35 | 736.71 | 859.63 | 905.03 | 903.52 | 884.78 | 828.58 | 743.23 | 684.33 | 744.85 |
Columns are period end dates